Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Polarization of macrophages and microglia in inflammatory demyelination.
Intrathecal baclofen pump for spasticity: an evidence-based analysis.
Clinical use of brain volumetry.
Rotating-polarization CARS microscopy: combining chemical and molecular orientation sensitivity.
Stress-stimulated volitional coping competencies and depression in multiple sclerosis.
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Pathophysiological processes in multiple sclerosis: focus on nuclear factor erythroid-2-related factor 2 and emerging pathways.
Multiple sclerosis and pregnancy.
Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase.
Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort.
Inflammatory Cytokines Are Involved in Focal Demyelination in Leprosy Neuritis.
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease.
Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis.
Gilenya Safety Update
Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.
Neuromyelitis optica overlapping systemic sclerosis with anti-centromere antibodies.
Vitamin D supplementation, moderate sun exposure, and control of immune Diseases.
Functional brain imaging: an evidence-based analysis.
Early presentation of neuromyelitis optica.
Increased CSF sulfatide levels and serum glycosphingolipid antibody levels in healthy siblings of multiple sclerosis patients.
Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems.
Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.
Clinical and neuroimaging correlation of movement disorders in multiple sclerosis: case series and review of the literature.
The impact of neuromyelitis optica on the recognition of emotional facial expressions: A preliminary report.
Update on Disease-Modifying Treatments for Multiple Sclerosis.
Pages
« first
‹ previous
…
394
395
396
397
398
399
400
401
402
…
next ›
last »